735 related articles for article (PubMed ID: 24646561)
1. Parenchyma-sparing pancreatectomy for presumed noninvasive intraductal papillary mucinous neoplasms of the pancreas.
Sauvanet A; Gaujoux S; Blanc B; Couvelard A; Dokmak S; Vullierme MP; Ruszniewski P; Belghiti J; Lévy P
Ann Surg; 2014 Aug; 260(2):364-71. PubMed ID: 24646561
[TBL] [Abstract][Full Text] [Related]
2. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
[TBL] [Abstract][Full Text] [Related]
3. [Limited pancreatic resections for intraductal papillary mucinous neoplasm].
Blanc B; Sauvanet A; Couvelard A; Pessaux P; Dokmak S; Vullierme MP; Lévy P; Ruszniewski P; Belghiti J
J Chir (Paris); 2008; 145(6):568-78. PubMed ID: 19106888
[TBL] [Abstract][Full Text] [Related]
4. Inferior head resection of the pancreas for intraductal papillary mucinous neoplasms.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kobayashi S; Kojima M; Miyauchi H; Asano T
J Hepatobiliary Pancreat Sci; 2010 Nov; 17(6):798-802. PubMed ID: 19727540
[TBL] [Abstract][Full Text] [Related]
5. Surgical outcomes of noninvasive and minimally invasive intraductal papillary-mucinous neoplasms of the pancreas.
Takahashi H; Nakamori S; Nakahira S; Tsujie M; Takahshi Y; Marubashi S; Miyamoto A; Takeda Y; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
Ann Surg Oncol; 2006 Jul; 13(7):955-60. PubMed ID: 16788757
[TBL] [Abstract][Full Text] [Related]
6. Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis.
Marchegiani G; Mino-Kenudson M; Ferrone CR; Warshaw AL; Lillemoe KD; Fernández-del Castillo C
J Am Coll Surg; 2015 May; 220(5):839-44. PubMed ID: 25840549
[TBL] [Abstract][Full Text] [Related]
7. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive intraductal papillary mucinous neoplasms and mucinous cystic neoplasms: recurrence rates and postoperative imaging follow-up.
Xourafas D; Tavakkoli A; Clancy TE; Ashley SW
Surgery; 2015 Mar; 157(3):473-83. PubMed ID: 25596773
[TBL] [Abstract][Full Text] [Related]
9. Surgical strategy for main pancreatic duct-type intraductal papillary mucinous neoplasm of the pancreas.
Kuroki T; Adachi T; Ono S; Tanaka T; Kitasato A; Takatsuki M; Eguchi S
Hepatogastroenterology; 2012; 59(120):2631-4. PubMed ID: 22534541
[TBL] [Abstract][Full Text] [Related]
10. Long-term prospective cohort study of patients undergoing pancreatectomy for intraductal papillary mucinous neoplasm of the pancreas: implications for postoperative surveillance.
Kang MJ; Jang JY; Lee KB; Chang YR; Kwon W; Kim SW
Ann Surg; 2014 Aug; 260(2):356-63. PubMed ID: 24378847
[TBL] [Abstract][Full Text] [Related]
11. Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival.
Raut CP; Cleary KR; Staerkel GA; Abbruzzese JL; Wolff RA; Lee JH; Vauthey JN; Lee JE; Pisters PW; Evans DB
Ann Surg Oncol; 2006 Apr; 13(4):582-94. PubMed ID: 16523362
[TBL] [Abstract][Full Text] [Related]
12. Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
Ann Surg Oncol; 2007 Nov; 14(11):3174-80. PubMed ID: 17694416
[TBL] [Abstract][Full Text] [Related]
13. Patterns of Recurrence After Resection of IPMN: Who, When, and How?
Marchegiani G; Mino-Kenudson M; Ferrone CR; Morales-Oyarvide V; Warshaw AL; Lillemoe KD; Castillo CF
Ann Surg; 2015 Dec; 262(6):1108-14. PubMed ID: 25793719
[TBL] [Abstract][Full Text] [Related]
14. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.
Schnelldorfer T; Sarr MG; Nagorney DM; Zhang L; Smyrk TC; Qin R; Chari ST; Farnell MB
Arch Surg; 2008 Jul; 143(7):639-46; discussion 646. PubMed ID: 18645105
[TBL] [Abstract][Full Text] [Related]
15. Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience.
Yang AD; Melstrom LG; Bentrem DJ; Ujiki MB; Wayne JD; Strouch M; Bell RH; Rao SM; Talamonti MS
Surgery; 2007 Oct; 142(4):529-34; discussion 534-7. PubMed ID: 17950345
[TBL] [Abstract][Full Text] [Related]
16. Middle-preserving pancreatectomy: an interesting procedure for pancreas-sparing resection.
Sperti C; Polizzi ML; Moro M; Beltrame V; Pedrazzoli S
JOP; 2010 May; 11(3):258-61. PubMed ID: 20442523
[TBL] [Abstract][Full Text] [Related]
17. Intraductal papillary mucinous neoplasms of the pancreas--predictors of malignancy.
Fan F; Lai EC; Xie F; Yang JM; Xu F; Kan T; Shen RX; Yang XY; Lau Wan Y; Wu MC
Hepatogastroenterology; 2010; 57(99-100):635-9. PubMed ID: 20698241
[TBL] [Abstract][Full Text] [Related]
18. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes.
Minagawa N; Sato N; Mori Y; Tamura T; Higure A; Yamaguchi K
Eur J Surg Oncol; 2013 Jun; 39(6):554-8. PubMed ID: 23506840
[TBL] [Abstract][Full Text] [Related]
19. Invasive IPMN and MCN: same organ, different outcomes?
Kargozaran H; Vu V; Ray P; Bagaria S; Steen S; Ye X; Gagandeep S
Ann Surg Oncol; 2011 Feb; 18(2):345-51. PubMed ID: 20809175
[TBL] [Abstract][Full Text] [Related]
20. Nonoperative management of main pancreatic duct-involved intraductal papillary mucinous neoplasm might be indicated in select patients.
Roch AM; DeWitt JM; Al-Haddad MA; Schmidt CM; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
J Am Coll Surg; 2014 Jul; 219(1):122-9. PubMed ID: 24862887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
